These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 16676354)
1. The impact of cell adhesion changes on proliferation and survival during prostate cancer development and progression. Knudsen BS; Miranti CK J Cell Biochem; 2006 Oct; 99(2):345-61. PubMed ID: 16676354 [TBL] [Abstract][Full Text] [Related]
2. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Bonkhoff H; Remberger K Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398 [TBL] [Abstract][Full Text] [Related]
3. Molecular regulation of androgen action in prostate cancer. Dehm SM; Tindall DJ J Cell Biochem; 2006 Oct; 99(2):333-44. PubMed ID: 16518832 [TBL] [Abstract][Full Text] [Related]
4. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression. Yang Q; Titus MA; Fung KM; Lin HK J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593 [TBL] [Abstract][Full Text] [Related]
5. Emergence of metastatic hormone-refractory disease in prostate cancer after anti-androgen therapy. Lee EC; Tenniswood MP J Cell Biochem; 2004 Mar; 91(4):662-70. PubMed ID: 14991758 [TBL] [Abstract][Full Text] [Related]
6. Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer. Agoulnik IU; Vaid A; Nakka M; Alvarado M; Bingman WE; Erdem H; Frolov A; Smith CL; Ayala GE; Ittmann MM; Weigel NL Cancer Res; 2006 Nov; 66(21):10594-602. PubMed ID: 17079484 [TBL] [Abstract][Full Text] [Related]
7. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells. Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760 [TBL] [Abstract][Full Text] [Related]
8. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer. Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687 [TBL] [Abstract][Full Text] [Related]
9. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways. Vis AN; Schröder FH BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of prostate cancer progression to androgen independence. McPhaul MJ Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):373-88. PubMed ID: 18471793 [TBL] [Abstract][Full Text] [Related]
11. E-cadherin-mediated survival of androgen-receptor-expressing secretory prostate epithelial cells derived from a stratified in vitro differentiation model. Lamb LE; Knudsen BS; Miranti CK J Cell Sci; 2010 Jan; 123(Pt 2):266-76. PubMed ID: 20048343 [TBL] [Abstract][Full Text] [Related]
12. Androgen receptor regulates CD168 expression and signaling in prostate cancer. Lin SL; Chang D; Chiang A; Ying SY Carcinogenesis; 2008 Feb; 29(2):282-90. PubMed ID: 18174258 [TBL] [Abstract][Full Text] [Related]
13. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion. Man YG; Gardner WA Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698 [TBL] [Abstract][Full Text] [Related]
14. Signal co-operation between integrins and other receptor systems. Streuli CH; Akhtar N Biochem J; 2009 Mar; 418(3):491-506. PubMed ID: 19228122 [TBL] [Abstract][Full Text] [Related]
15. Androgen receptor and invasion in prostate cancer. Hara T; Miyazaki H; Lee A; Tran CP; Reiter RE Cancer Res; 2008 Feb; 68(4):1128-35. PubMed ID: 18281488 [TBL] [Abstract][Full Text] [Related]
16. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells. Fujimoto N; Miyamoto H; Mizokami A; Harada S; Nomura M; Ueta Y; Sasaguri T; Matsumoto T Cancer Invest; 2007 Feb; 25(1):32-7. PubMed ID: 17364555 [TBL] [Abstract][Full Text] [Related]
17. Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells. Hsieh CL; Cai C; Giwa A; Bivins A; Chen SY; Sabry D; Govardhan K; Shemshedini L J Mol Endocrinol; 2008 Jul; 41(1):13-23. PubMed ID: 18469090 [TBL] [Abstract][Full Text] [Related]
18. Emerging views of integrin signaling: implications for prostate cancer. Slack-Davis JK; Parsons JT J Cell Biochem; 2004 Jan; 91(1):41-6. PubMed ID: 14689580 [TBL] [Abstract][Full Text] [Related]
19. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer. Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446 [TBL] [Abstract][Full Text] [Related]
20. Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer cells. Kim J; Park H; Im JY; Choi WS; Kim HS Anticancer Res; 2007; 27(5A):3285-92. PubMed ID: 17970072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]